Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Spotlight on 5-HT1B/1D agonists for migraine

July 1, 1998

Glutamate transport blockers discovered using novel system developed at Suntory

July 1, 1998

Zaleplon shows advantage over zolpidem for sleep disorders in phase III

June 30, 1998

Biovail granted license to Celgene's ADHD treatment

June 29, 1998

CoCensys initiates phase II migraine study with ganaxolone tablets

June 29, 1998

Quadramet approved in Canada

June 26, 1998

HMR withdraws cerebral metabolic enhancer from Japanese market; development in AD continues

June 26, 1998

Cathepsin B and L inhibitors claimed by Canadian researchers

June 26, 1998

Sibia Neurosciences initiates phase I trial with SIB-1553A

June 26, 1998

Selective 5-HT1F agonists claimed to be particularly useful for migraine, chronic pain

June 25, 1998